Trustee of MedAccess Trust
James Droop has a long track record of experience in international development and global health, with particular expertise in market shaping and access to health commodities, innovative finance and global health policy, strategy and governance.
He currently works as a consultant and prior to that worked at the UK government’s Foreign, Commonwealth and Development Office FCDO – previously DFID). While there he led the UK government’s large global health market shaping portfolio, including funding to Unitaid, UNFPA Supplies and the Clinton Health Access Initiative (CHAI).
He has co-created several innovative access initiatives, such as MedAccess; the Advance Market Commitment (AMC) for the pneumococcal vaccine; SEMA Reproductive Health (RH), a new partnership for RH commodity access; ATscale, the global partnership for assistive technology; and the UNFPA Bridge Funding Mechanism.
He was the UK representative to the G7 Health Experts’ group and also led UK government work to accelerate the development and rollout of Ebola vaccines during the 2014 outbreak as well as supporting efforts to drive access to vaccines, treatments and tests during the Covid-19 response.
James has also worked at the World Bank, IMF, UK Treasury and as a consultant with Oxford Economics and Oxford Policy Management (OPM).